Clinical Trial Update: A Pharmacokinetic Study of the Relative Bioavailability of Paliperidone ER Formulations With Different Release Profiles and a Comparison to Paliperidone IR [Phase 1]

View source ↗

Summary

This Phase 1 pharmacokinetic study assesses the relative bioavailability of paliperidone extended-release formulations with different release profiles and compa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Paliperidone ER (paliperidone)
• Paliperidone IR (paliperidone immediate-release)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED